Vidvan Image

Dr Nandini Verma

vidwan id: 171417
Female

Scientific Officer E, Cancer Research Institute
Advanced Centre for Treatment, Research and Education in Cancer

Expertise

  • Biochemistry and Molecular Biology

Publications

Total Articles 17
Books 0
Proceedings 0

Publications

No publication activity to display at the moment.

Scopus

Citations 493
h-index 12

CrossRef

CrossRef Icon
Citations 537
h-index 11
Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Bio

Breast Cancer Research

Personal Details

  • Female
  • Scientific Officer E , Advanced Centre for Treatment, Research and Education in Cancer
  • Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Plot No. 1& 2, Kharghar
Ph.D
Other Institute 2012
Scientific Officer E Jul 2019 – Present
Advanced Centre for Treatment, Research and Education in Cancer | Cancer Research Institute

Related Profiles

Experts (1229+)

View All
Abhishek

Mr Abhishek Agarwal

Assistant Professor

Preeti

Dr Preeti Sharma

Assistant Professor

Pavithra

Pavithra Velayutham

Assistant Professor

Mahaboob

Dr Mahaboob Basha

Physical Director

HIBA

HIBA -

Assistant Professor

Muskan

Dr Muskan Jain (PT)

Assistant Professor

Shalini

Ms Shalini Saini

Assistant Professor

Organisations (107+)

View All
Ashok

Dr Ashok Varma

Principal Investigator

Atanu

Dr Atanu Bhattacharjee

Assistant Professor

Asawari

Dr Asawari Patil

Associate Professor

Kiran

Dr Kiran Bendale

Scientific Officer C

Bhakti

Dr Bhakti Trivedi

Associate Professor

Nirmal Kumar

Dr Nirmal Kumar

Scientific Officer D

Anand

Mr Anand Patil

Scientific Officer C

Amol

Dr Amol Kothekar

Associate Professor

Co-Authors (12)

Manisha

Prof Manisha Goel

University of Delhi

Hemant

Dr Hemant Gautam

CSIR-Institute of Genomics and Integrative Biology

Manoj

Prof Manoj Pandey

Banaras Hindu University

Pardha Saradhi

Prof Pardha Saradhi P

University of Delhi

Poonam

Dr Poonam Gera

Advanced Centre for Treatment, Research and Education in Cancer

Rahul

Dr Rahul Thorat

Advanced Centre for Treatment, Research and Education in Cancer

Rajinder K

Prof Rajinder K Gupta

Delhi Technological University

Sorab

Dr Sorab Dalal

Advanced Centre for Treatment, Research and Education in Cancer

Jai

Prof Jai Gopal Sharma

Delhi Technological University

Siddhesh

Dr Siddhesh Kamat

Indian Institute of Science Education and Research(IISER), Pune

Surinder

Prof Surinder Jaswal

Tata Institute of Social Sciences

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer

Open Access
Article
Authors: Jog E.;Jainarayanan A.K.;La Ferlita A.;Chakraborty A.;Dalwai A.;Yahya S.;Shivashankar A.;Choudhary B.S.;Chandramouli A.;Kazi M.;Jain D.;Khapare N.;B A.;Khan B.K.;Gera P.;Patil P.;Thorat R.;Verma N.;Sehgal L.;Saklani A.;Kamat S.S.;Dalal S.N.;Chaudhary N.

Symposium report: breast cancer in India—trends, environmental exposures and clinical implications

Open Access
Review
Authors: McDonald J.A.;Rao R.;Gibbons M.;Janardhanan R.;Jaswal S.;Mehrotra R.;Pandey M.;Radhakrishnan V.;Ramakant P.;Verma N.;Terry M.B.

Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis

Open Access
Article
Authors: Verma N.;Vinik Y.;Saroha A.;Nair N.U.;Ruppin E.;Mills G.;Karn T.;Dubey V.;Khera L.;Raj H.;Maina F.;Lev S.

Correction: Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4–NDRG1 axis (Cancer Research (2017) 77 (86–99) DOI: 10.1158/0008-5472.CAN-16-1797)

Open Access
Erratum
Authors: Verma N.;Muller A.K.;Kothari C.;Panayotopoulou E.;Kedan A.;Selitrennik M.;Mills G.B.;Nguyen L.K.;Shin S.;Karn T.;Holtrich U.;Lev S.

HER family in cancer progression: From discovery to 2020 and beyond

Open Access
Book Chapter
Authors: Kumar R.;George B.;Campbell M.R.;Verma N.;Paul A.M.;Melo-Alvim C.;Ribeiro L.;Pillai M.R.;da Costa L.M.;Moasser M.M.

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

Open Access
Article
Authors: Kedan A.;Verma N.;Saroha A.;Shreberk-Shaked M.;Müller A.K.;Nair N.U.;Lev S.

Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer

Open Access
Article
Authors: Shin S.Y.;Müller A.K.;Verma N.;Lev S.;Nguyen L.K.

Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4-NDRG1 axis

Open Access
Article
Authors: Verma N.;Müller A.K.;Kothari C.;Panayotopoulou E.;Kedan A.;Selitrennik M.;Mills G.B.;Nguyen L.K.;Shin S.;Karn T.;Holtrich U.;Lev S.